Statement from FDA Commissioner Scott Gottlieb, M.D. on steps toward a new, tailored review framework for artificial intelligence-based medical devices

Statement from FDA Commissioner Scott Gottlieb, M.D. on steps toward a new, tailored review framework for artificial intelligence-based medical devices

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm635083.htm

Source: Food and Drug Administration - April 2, 2019 Category: American Health Source Type: news

More News: American Health | Food and Drug Administration (FDA) | Medical Devices